Home › Funds › Egerton Capital (UK) LLP › APH
Egerton Capital (UK) LLP position in APH
AMPHENOL CORPORATION · Technology
Egerton Capital (UK) LLP reported holding 10,708,713 shares of APH (AMPHENOL CORPORATION) in its Q3 2026 13F filing — a position valued at US$902.7M, representing 9.19% of its reported portfolio and ranking #3 among its reported holdings. Egerton Capital (UK) LLP has disclosed APH holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Egerton Capital (UK) LLP's APH position evolved
Egerton Capital (UK) LLP first disclosed a stake in APH in Q1 2025 at 1,762,623 shares (US$115.6M). The position peaked in Q3 2026 at 10,708,713 shares, worth US$902.7M. Across 7 filings, Egerton Capital (UK) LLP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,708,713 shares valued at US$902.7M — an increase of 5,842,025 shares quarter over quarter.. Notable position changes include a 80% increase in Q2 2025 (shares rose 25% over the following quarter), a 69% increase in Q2 2026 (shares fell 4% over the following quarter), a 120% increase in Q3 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.76M | $115.61M | New |
| Q2 2025 | 3.17M | $312.89M | Add |
| Q3 2025 | 3.82M | $473.15M | Add |
| Q4 2025 | 3.71M | $501.09M | Reduce |
| Q1 2026 | 2.87M | $362.80M | Reduce |
| Q2 2026 | 4.87M | $858.09M | Add |
| Q3 2026 | 10.71M | $902.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APH and 13F data
APH (AMPHENOL CORPORATION) is a Technology company. 45 other funds we track also report a position in APH — the largest reported positions include BlackRock Inc (US$17.85B), Fidelity Management & Research (FMR) (US$10.58B), Capital International Investors (US$7.30B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APH
- BlackRock Inc 101.25M sh · $17.85B · Q2 2026
- Fidelity Management & Research (FMR) 125.45M sh · $10.58B · Q3 2026
- Capital International Investors 86.54M sh · $7.30B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 72.02M sh · $6.07B · Q3 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 32.01M sh · $5.64B · Q2 2026
- Capital Research Global Investors 63.41M sh · $5.35B · Q3 2026
- Capital Research Global Investors 29.49M sh · $5.20B · Q2 2026
- JPMorgan Chase & Co 60.46M sh · $5.10B · Q3 2026
- Wellington Management Group 16.58M sh · $2.92B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 16.58M sh · $2.92B · Q2 2026
- BNY Mellon 26.77M sh · $2.26B · Q3 2026
- Arrowstreet Capital 11.89M sh · $2.10B · Q2 2026
More on Egerton Capital (UK) LLP
FAQ
How long has Egerton Capital (UK) LLP held APH?
Egerton Capital (UK) LLP has disclosed APH holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Egerton Capital (UK) LLP's current position in APH?
As of Q3 2026, Egerton Capital (UK) LLP holds 10.71M shares of APH (AMPHENOL CORPORATION), valued at $902.74M, representing 9.19% of its reported portfolio and ranking #3.
Has Egerton Capital (UK) LLP been buying or selling APH?
In the latest 13F filing (Q3 2026), Egerton Capital (UK) LLP increased its position in APH. The position peaked in Q3 2026 at 10.71M shares.
Which other funds hold APH?
Other major institutional holders of APH include BlackRock Inc, Fidelity Management & Research (FMR), Capital International Investors, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.